- Home
- OPK vs IMAX Comparison
OPK vs IMAX Comparison
Compare OPK & IMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OPK | IMAX |
|---|---|---|
| Founded | 2007 | 1967 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 2.0B |
| IPO Year | 1995 | 1994 |
Fundamental Metrics
Financial Performance| Metric | OPK | IMAX |
|---|---|---|
| Price | $1.38 | $38.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | $2.28 | ★ $39.44 |
| AVG Volume (30 Days) | ★ 2.8M | 1.6M |
| Earning Date | 10-29-2025 | 10-23-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 62.41 |
| EPS | N/A | ★ 0.71 |
| Revenue | ★ $642,067,000.00 | $377,677,000.00 |
| Revenue This Year | N/A | $17.44 |
| Revenue Next Year | N/A | $6.23 |
| P/E Ratio | ★ N/A | $53.26 |
| Revenue Growth | N/A | ★ 9.30 |
| 52 Week Low | $1.11 | $20.48 |
| 52 Week High | $2.04 | $38.89 |
Technical Indicators
Market Signals| Indicator | OPK | IMAX |
|---|---|---|
| Relative Strength Index (RSI) | 52.93 | 61.18 |
| Support Level | $1.28 | $37.72 |
| Resistance Level | $1.35 | $38.77 |
| Average True Range (ATR) | 0.05 | 1.57 |
| MACD | 0.01 | 0.12 |
| Stochastic Oscillator | 68.30 | 86.25 |
Price Performance
Historical ComparisonAbout OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
About IMAX Imax Corporation
Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.